TB-500 (Thymosin Beta-4)

This review synthesizes the molecular biology of Thymosin Beta-4 and its observed activities in preclinical models. The authors describe Tβ4's primary intracellular role as a G-actin sequestering protein that regulates cytoskeletal dynamics, and its secreted activities including modulation of stem and progenitor cell migration, angiogenesis via VEGF and laminin pathways, and downregulation of pro-inflammatory cytokines. The review summarizes preclinical evidence across dermal, corneal, cardiac, and central nervous system injury models, where systemic or topical Tβ4 administration was associated with accelerated repair and reduced inflammatory infiltrate.

Researchers reviewed everything known at the time about Thymosin Beta-4 — the peptide that TB-500 is the synthetic version of. Inside cells, it acts like a manager that organizes the cell's internal scaffolding. When it's released outside the cell, it appears to help wound healing in multiple ways: it helps stem cells move to where they're needed, helps new blood vessels form, and quiets the inflammation signals that can slow repair. Animal studies in skin, eye, heart, and brain injury models all showed signs of faster recovery when Tβ4 was given.

Using genetic lineage tracing in adult mice, the authors demonstrated that Thymosin Beta-4 administration mobilized quiescent epicardium-derived progenitor cells, inducing their proliferation, migration into the myocardium, and differentiation toward endothelial fates. The result was increased capillary density in regions of cardiac injury. The effect required functional Tβ4 and was associated with restoration of pluripotency markers in adult epicardial cells, suggesting that Tβ4 reactivates a developmental program normally dormant in adult tissue.

Scientists studied how Thymosin Beta-4 affects the outer layer of the heart in adult mice. They found that the peptide woke up sleeping stem-like cells in this layer, made them divide, and prompted them to migrate into damaged heart tissue where they started forming new blood vessels. In effect, Tβ4 seemed to switch on a repair program that the adult heart had stopped using since development.